Indicaton

AUP-16 multi-targeting therapy for chronic wounds (Diabetic Foot Ulcers...) shows 50% improvement vs placebo in Phase-2 RCT

Therapeutic indications
Table
  • Phase
    Phase II completed
  • Partnering status
    Not partnered